Offer - Urjas Oil for just ₹ 1 X
Telplus Trio 40/10/12.5 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Telplus Trio 40/10/12.5 Tablet have also been mentioned below.
The right dosage of Telplus Trio 40/10/12.5 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Telplus Trio 40/10/12.5 Tablet include Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Telplus Trio 40/10/12.5 Tablet as well, which are listed below. Such side effects of Telplus Trio 40/10/12.5 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Telplus Trio 40/10/12.5 Tablet's effect during pregnancy is Mild and Mild while nursing. Warnings related to Telplus Trio 40/10/12.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Telplus Trio 40/10/12.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Telplus Trio 40/10/12.5 Tablet in conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia. Other conditions have been mentioned below in the Telplus Trio 40/10/12.5 Tablet contraindications section.
Drug reaction of Telplus Trio 40/10/12.5 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Telplus Trio 40/10/12.5 Tablet is considered not safe while driving, and is not addictive.
Telplus Trio 40/10/12.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telplus Trio 40/10/12.5 Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Telplus Trio has mild side effects when taken during pregnany
Is the use of Telplus Trio 40/10/12.5 Tablet safe during breastfeeding?
Telplus Trio has been seen to have minimal side effects on breastfeeding women.
What is the effect of Telplus Trio 40/10/12.5 Tablet on the Kidneys?
Telplus Trio has very mild side effects on the kidneys.
What is the effect of Telplus Trio 40/10/12.5 Tablet on the Liver?
Side effects of Telplus Trio rarely affect the liver.
What is the effect of Telplus Trio 40/10/12.5 Tablet on the Heart?
Very few cases of side effects of Telplus Trio on the heart have been reported.
Telplus Trio 40/10/12.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telplus Trio 40/10/12.5 Tablet unless your doctor advises you to do so -
Is this Telplus Trio 40/10/12.5 Tablet habit forming or addictive?
Telplus Trio 40/10/12.5 Tablet is not addictive in nature.
Interaction between Food and Telplus Trio 40/10/12.5 Tablet
When consumed with certain foods, Telplus Trio 40/10/12.5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Telplus Trio 40/10/12.5 Tablet
Consuming Telplus Trio 40/10/12.5 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448